Financials Novoray Corporation

Equities

688300

CNE100003PN0

Commodity Chemicals

End-of-day quote Shanghai S.E. 23:00:00 27/06/2024 BST 5-day change 1st Jan Change
48.1 CNY +1.16% Intraday chart for Novoray Corporation -10.48% -9.16%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,907 4,026 9,532 6,069 9,835 8,934 - -
Enterprise Value (EV) 1 3,907 4,026 9,532 6,069 9,835 8,934 8,934 8,934
P/E ratio 52.3 x 36.3 x 55.2 x 32.2 x 56.3 x 38.8 x 30.1 x 23.9 x
Yield 1.1% 1.07% 0.55% - 0.94% 0.69% 0.94% 0.98%
Capitalization / Revenue 12.4 x 9.96 x 15.3 x 9.17 x 13.8 x 9.95 x 8.07 x 6.68 x
EV / Revenue 12.4 x 9.96 x 15.3 x 9.17 x 13.8 x 9.95 x 8.07 x 6.68 x
EV / EBITDA - 28.7 x 43.3 x - 40.1 x 27.3 x 22.3 x 17.8 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 4.36 x 4.18 x 8.72 x 4.93 x 7.3 x 5.88 x 5.05 x 4.36 x
Nbr of stocks (in thousands) 185,746 185,746 185,746 185,746 185,746 185,746 - -
Reference price 2 21.04 21.68 51.32 32.67 52.95 48.10 48.10 48.10
Announcement Date 27/02/20 23/02/21 27/02/22 27/02/23 22/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 315.3 404.2 624.7 662 711.7 898.2 1,107 1,337
EBITDA 1 - 140.2 220.2 - 245 327 400 501
EBIT 1 85.13 123.9 197.2 190.2 195.4 258.4 331.6 418.5
Operating Margin 27% 30.65% 31.57% 28.73% 27.45% 28.77% 29.94% 31.3%
Earnings before Tax (EBT) 1 86.83 128.4 197.4 193.2 197.4 261 334.4 421.2
Net income 1 74.69 110.9 172.9 188.2 174 230.1 297 374
Net margin 23.69% 27.44% 27.67% 28.44% 24.45% 25.62% 26.82% 27.98%
EPS 2 0.4022 0.5971 0.9303 1.013 0.9400 1.240 1.600 2.012
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.2314 0.2314 0.2814 - 0.5000 0.3300 0.4500 0.4700
Announcement Date 27/02/20 23/02/21 27/02/22 27/02/23 22/02/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 19.2% 12% 16.9% 16.3% 13.6% 14.9% 16.9% 18.1%
ROA (Net income/ Total Assets) - 10.5% 14.4% - 13.5% 11.8% 13.1% 13.9%
Assets 1 - 1,058 1,199 - 1,289 1,944 2,274 2,687
Book Value Per Share 2 4.820 5.190 5.890 6.620 7.250 8.180 9.530 11.00
Cash Flow per Share 2 0.4300 0.4800 0.8300 1.300 1.330 1.030 1.450 1.830
Capex 1 60.3 124 208 155 52.9 144 139 114
Capex / Sales 19.14% 30.7% 33.27% 23.39% 7.44% 16.03% 12.51% 8.53%
Announcement Date 27/02/20 23/02/21 27/02/22 27/02/23 22/02/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
48.1 CNY
Average target price
53 CNY
Spread / Average Target
+10.19%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688300 Stock
  4. Financials Novoray Corporation